Breast cancer is divided into five subtypes based on surface molecule expression: Luminal A, luminal B, human epidermal growth factor receptor 2 positive (HER2), luminal B-HER2, and triple negative breast cancer (TNBC) (3). This evidence concerns the gene ERBB2 and triple-negative breast carcinoma.